Skip to main content

Table 3 Univariate and multivariate of overall survival in 130 patients with HCC of grade III and IV

From: Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma

Variables

Univariate analysis

Multivariate analysis

Hazard Ratio

CI 95%

P

Hazard Ratio

CI 95%

P

Age (≤60 / > 60)

1.02

0.99–1.05

0.15

   

Gender (M / F)

0.99

0.49–2.02

0.979

   

AJCC stage (I + II / III + IV)

1.3

0.88–1.91

0.182

   

COMMD1 (high / low)

1.33

0.67–2.63

0.416

   

COMMD2 (high / low)

1.28

0.64–2.58

0.485

   

COMMD3 (high / low)

2.82

1.4–5.7

0.004*

2.82

1.4–5.7

0.004*

COMMD4 (high / low)

0.8

0.4–1.61

0.534

   

COMMD5 (high / low)

1.95

0.98–3.9

0.057

   

COMMD6 (high / low)

1.21

0.61–2.4

0.586

   

COMMD7 (high / low)

0.76

0.37–1.58

0.466

   

COMMD8 (high / low)

1.5

0.75–2.98

0.254

   

COMMD9 (high / low)

1.32

0.63–2.78

0.467

   

COMMD10 (high / low)

1.12

0.55–2.28

0.756

   
  1. HCC Hepatocellular carcinoma, CI Confidence interval. * p < 0.05.